Two Sigma Advisers
SRNE

Two Sigma Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Two Sigma Advisers’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-21,200
Closed -$245K – 2125
2015
Q1 		$245K Buy
21,200
+10,000
+89% +$116K ﹤0.01% 1661
2014
Q4 		$113K Buy
+11,200
New +$56.7K ﹤0.01% 2312

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers's SRNE Position: Q2 2015 in Review

Two Sigma Advisers sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2015, closing a stake of 21,200 shares — an estimated $245K sold.

Two Sigma Advisers first reported a position in SRNE in Q4 2014 and held it in 2 quarters. The position peaked at $245K in Q1 2015. 75 funds tracked by Wall St. Rank hold SRNE as of Q2 2015.

  • Two Sigma Advisers reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Two Sigma Advisers sold 21,200 Sorrento Therapeutics, Inc. shares in Q2 2015, an estimated $245K.
  • Two Sigma Advisers first reported a position in Sorrento Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
  • Two Sigma Advisers's Sorrento Therapeutics, Inc. position peaked at $245K in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2015.

Based on Two Sigma Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.